menu
    • menu
    [{"orgOrder":0,"company":"Curanex Pharmaceuticals","sponsor":"Dominari Securities","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2025","type":"Public Offering","leadProduct":"Phyto-N","moa":"Undisclosed","graph1":"Immunology","graph2":"Preclinical","graph3":"Curanex Pharmaceuticals","amount2":0.02,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Immunology","amount2New":0.02,"dosageForm":"Undisclosed","sponsorNew":"Curanex Pharmaceuticals \/ Dominari Securities","highestDevelopmentStatusID":"4","companyTruncated":"Curanex Pharmaceuticals \/ Dominari Securities"}]

    Find Clinical Drug Pipeline Developments & Deals by Curanex Pharmaceuticals

    Menu

    Curanex Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Curanex Pharmaceuticals

                            U.S.A arrow
                            ESCRS
                            Not Confirmed

                            Curanex Pharmaceuticals

                            U.S.A arrow
                            ESCRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Phyto-N

                            Therapeutic Area : Immunology

                            Study Phase : Preclinical

                            Sponsor : Dominari Securities

                            Deal Size : $15.0 million

                            Deal Type : Public Offering

                            DEALS_DEV arrow-down

                            Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering

                            Details : The Company intends to use the proceeds from the Offering for the development of its lead product candidate, Phyto-N, for the treatment of ulcerative colitis.

                            Product Name : Phyto-N

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Undisclosed

                            August 26, 2025

                            Lead Product(s) : Phyto-N

                            Therapeutic Area : Immunology

                            Highest Development Status : Preclinical

                            Sponsor : Dominari Securities

                            Deal Size : $15.0 million

                            Deal Type : Public Offering

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth